Where to now? In a post-vioxx world, what's next for COX-2 inhibitors?
Contribuinte(s) |
G. Smith |
---|---|
Data(s) |
01/01/2005
|
Identificador | |
Publicador |
Reed Business Information |
Palavras-Chave | #CX #320501 Pharmaceutical Sciences and Pharmacy #730301 Health education and promotion |
Tipo |
Journal Article |